NASDAQ:TYME Tyme Technologies (TYME) Stock Price, News & Analysis → Did you make $29,000 two days with AI options trades? (From Prosper Trading Academy) (Ad) Free TYME Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.29▼$0.3250-Day Range$0.24▼$0.3552-Week Range$0.22▼$1.14Volume2.68 million shsAverage Volume1.01 million shsMarket Capitalization$53.50 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Tyme Technologies alerts: Email Address Ad The Bull ReportThe AI Bottleneck No One is Talking AboutRenewable energy is growing at an impressive speed - but not fast enough. This could be one of the greatest periods for the nuclear industry ever.Click here to see who's preparing to meet these needs About Tyme Technologies Stock (NASDAQ:TYME)Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also developing TYME-19, an oral synthetic member of the bile acid family, which is in preclinical stage for the treatment of SARS CoV-2 diseases; and TYME-18, a CMBT compound that is in preclinical stage for the treatment of inoperable tumors. It has research collaborations with Mayo Clinic to perform in-depth analysis of pancreatic cancer cell gene expression, epigenetic, and metabolism changes from SM-88 treatment; and a research investigator at Georgetown University to examine the effects of SM-88 in breast cancer. The company was formerly known as Global Group Enterprises Corp. The company was incorporated in 2011 and is headquartered in Bedminster, New Jersey.Read More Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now TYME Stock News HeadlinesMarch 15, 2024 | yahoo.com5 Kitchen Must-Haves For Your DIY LifestyleMarch 12, 2024 | msn.com8 Simple Habits of People Who Have a Thriving, Bird-Friendly BackyardMarch 19, 2024 | Banyan Hill Publishing (Ad)AI Cracks Open Largest Untapped Energy Reserve on EarthThis orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… March 11, 2024 | msn.comClos Apalta: fabulous wines from ChileFebruary 25, 2024 | msn.com‘Real music by real musicians’: New recording studio in Vandalia Tower aims to build sustainable music careers for youth of colorFebruary 24, 2024 | msn.comGokongwei-backed digital bank to launch ATM servicesFebruary 22, 2024 | news.yahoo.comPublic invited to BSU Sings! Day concert set for March 13February 22, 2024 | yahoo.comThe 8 Best New Colognes of 2024 (So Far)March 19, 2024 | Banyan Hill Publishing (Ad)AI Cracks Open Largest Untapped Energy Reserve on EarthThis orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… February 20, 2024 | msn.com“What is An Item That Everyone Misuses But The Makers Pretend They Don’t Know?” (32 Answers)February 16, 2024 | cbsnews.comWomen's HealthFebruary 3, 2024 | msn.comNinja Foodi Lamb ChopsFebruary 1, 2024 | msn.comThyme: Nutrition Professionals Guide You On Optimal Intake, Portions, And Health BenefitsJanuary 31, 2024 | msn.comHow to use essential oilsJanuary 31, 2024 | yahoo.comDespite glimmers of profit, most African neobanks remain in the redJanuary 24, 2024 | msn.comKeyrus unlocks powerful dynamic data visualisation for GoTyme BankJanuary 20, 2024 | msn.comCan You Put a Whole Chicken in an Air FryerJanuary 16, 2024 | tmcnet.comSingapore's Tyme Group delivers the world's fastest profitable standalone digital bank; over $215m annualised revenueJanuary 16, 2024 | finance.yahoo.comTymeBank South Africa Sees Unicorn Status in Next FundraisingJanuary 9, 2024 | msn.comCatnip holds great significance for сats: Scientists make unexpected claimJanuary 8, 2024 | startribune.comYou've built a business that's ready to sell. Here's how some Twin Cities entrepreneurs did it.January 6, 2024 | msn.comThe 10 Best Indoor Gardens Of 2024, Tested And ReviewedJanuary 3, 2024 | msn.comAre catnip and treats like it safe for cats? Here's how they affect their minds and moodsDecember 29, 2023 | msn.comAmid a changed restaurant industry, a look at eateries the Lansing area lost in 2023December 20, 2023 | msn.com29 Luxurious Fish Dishes For A Festive Christmas Eve DinnerDecember 19, 2023 | markets.businessinsider.comArbital Health Announces Esteemed Leadership Team and Advisory Board Accelerating Shift to Value-Based CareDecember 15, 2023 | msn.comJingle Bites: Holiday Snacks, Drinks & More That Sleigh the Flavor GameSee More Headlines Receive TYME Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tyme Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/08/2021Today3/19/2024Fiscal Year End3/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:TYME CUSIPN/A CIK1537917 Webwww.tymeinc.com Phone(212) 461-2315FaxN/AEmployees17Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.14) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-23,630,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-28.30% Return on Assets-26.21% Debt Debt-to-Equity RatioN/A Current Ratio14.06 Quick Ratio14.06 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.47 per share Price / Book0.66Miscellaneous Outstanding Shares172,207,000Free Float143,104,000Market Cap$53.50 million OptionableOptionable Beta0.93 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Richard Cunningham (Age 51)CEO & Director Comp: $789.9kMr. Steven E. Hoffman (Age 59)Co-Founder & Director Comp: $2.6MMr. Frank L. Porfido (Age 58)Chief Financial Officer Comp: $488.2kMr. James Biehl J.D. (Age 58)Chief Legal Officer & Sec. Comp: $635.89kDr. Jonathan M. Eckard (Age 48)Chief Bus. Officer Dr. Jan Marie-Albert Van Tornout M.D. (Age 66)M.Sc., Acting Chief Medical Officer More ExecutivesKey CompetitorsReneo PharmaceuticalsNASDAQ:RPHMHCW BiologicsNASDAQ:HCWBHomology MedicinesNASDAQ:FIXXLexaria BioscienceNASDAQ:LEXXTiziana Life SciencesNASDAQ:TLSAView All Competitors TYME Stock Analysis - Frequently Asked Questions How were Tyme Technologies' earnings last quarter? Tyme Technologies, Inc. (NASDAQ:TYME) announced its quarterly earnings results on Monday, November, 8th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.06) by $0.03. What other stocks do shareholders of Tyme Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Tyme Technologies investors own include Rigel Pharmaceuticals (RIGL), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), Vaxart (VXRT), Allena Pharmaceuticals (ALNA), OpGen (OPGN), Selecta Biosciences (SELB), MEI Pharma (MEIP), Pfizer (PFE) and SCYNEXIS (SCYX). This page (NASDAQ:TYME) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tyme Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.